Prism Capital Partners has sold a 157,000-square-foot life sciences building at its ON3 campus, in a sign of investor appetite for modern lab and research and development space.
After decades of consolidation by Big Pharma, demand for modern lab and diagnostic space in New Jersey is on the rise, fueling rent growth and pushing some developers to consider new laboratory projects.
Prism Capital Partners has relocated its headquarters to ON3, the mixed-use campus that it’s developing at the sprawling former Hoffmann-LaRoche campus in Nutley and Clifton.
Amid continued demand for high-end research and development space, Prism Capital Partners is planning a new ground-up laboratory building at its ON3 campus in Nutley and Clifton.
Prism Capital Partners has completed the first phase of major infrastructure improvements at its ON3 campus in Nutley and Clifton, as it continues to ready the site for new tenants and additional construction.
Prism Capital Partners has detailed its plans for the Nutley office building that will become home to Ralph Lauren Corp., the latest tenant to commit to its 116-acre ON3 campus.
Prism Capital Partners has launched nearly $10 million in roadway and utility upgrades at the former Hoffmann-LaRoche campus in Nutley and Clifton, as it prepares to welcome new tenants to the 116-acre redevelopment site.
A growing pipeline of young life sciences firms has offered a second chance for New Jersey’s stock of legacy laboratory space. In the process, the ventures have served as anchors for developers seeking to repopulate large, vacant pharmaceutical campuses with turnkey laboratories.
Despite years of consolidation by Big Pharma, New Jersey is one of a handful of markets that stand to gain from a promising growth trajectory for the U.S. life sciences sector.
Prism Capital Partners has assembled a team to oversee its new ON3 campus in Nutley and Clifton, including three former Hoffmann-La Roche employees who worked at the site for a combined 90 years.
